FR2294712B1 - - Google Patents

Info

Publication number
FR2294712B1
FR2294712B1 FR7538626A FR7538626A FR2294712B1 FR 2294712 B1 FR2294712 B1 FR 2294712B1 FR 7538626 A FR7538626 A FR 7538626A FR 7538626 A FR7538626 A FR 7538626A FR 2294712 B1 FR2294712 B1 FR 2294712B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7538626A
Other versions
FR2294712A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CEPBEPE
Original Assignee
CEPBEPE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CEPBEPE filed Critical CEPBEPE
Publication of FR2294712A1 publication Critical patent/FR2294712A1/fr
Application granted granted Critical
Publication of FR2294712B1 publication Critical patent/FR2294712B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7538626A 1974-12-18 1975-12-17 Medicament regulateur de la glycemie, a base de guanosine Granted FR2294712A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5458274 1974-12-18

Publications (2)

Publication Number Publication Date
FR2294712A1 FR2294712A1 (fr) 1976-07-16
FR2294712B1 true FR2294712B1 (fr) 1978-07-28

Family

ID=10471478

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7538626A Granted FR2294712A1 (fr) 1974-12-18 1975-12-17 Medicament regulateur de la glycemie, a base de guanosine

Country Status (3)

Country Link
US (1) US4035486A (fr)
DE (1) DE2554453A1 (fr)
FR (1) FR2294712A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729989A (en) * 1985-06-28 1988-03-08 Merck & Co., Inc. Enhancement of absorption of drugs from gastrointestinal tract using choline ester salts
US5449522A (en) * 1993-08-24 1995-09-12 Hill; Albert F. Pharmaceutical composition for immunoenhancement therapy
US5840770A (en) * 1993-08-24 1998-11-24 Hill Medical Corporation Method of killing tumor cells
AU709454B2 (en) * 1994-07-25 1999-08-26 Alvin J. Glasky Carbon monoxide dependent guanylyl cyclase modifiers
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004452A2 (fr) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Procédés pour le traitement de neuropathie périphérique induite par une pathologie et des états connexes
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives

Also Published As

Publication number Publication date
DE2554453A1 (de) 1976-06-24
US4035486A (en) 1977-07-12
FR2294712A1 (fr) 1976-07-16

Similar Documents

Publication Publication Date Title
FR2295405B1 (fr)
AU495930B2 (fr)
FR2289618B1 (fr)
AU480247A (fr)
AU480208A (fr)
AU480471A (fr)
AU480758A (fr)
AU480863A (fr)
BG19768A1 (fr)
BG19847A1 (fr)
BG19987A1 (fr)
BG20440A1 (fr)
BG20446A1 (fr)
BG20451A1 (fr)
BG20462A1 (fr)
BG20638A1 (fr)
BG20854A1 (fr)
BG20883A1 (fr)
BG20885A1 (fr)
BG20950A1 (fr)
BG21129A1 (fr)
BG21307A1 (fr)
BG21351A1 (fr)
BG21352A1 (fr)
BG21526A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse